| Jacquelyn Lea Allen, DO | |
|
7450 Kessler St, Ste 300, Merriam, KS 66204 | |
| (913) 632-2900 | |
| (913) 632-2999 |
| Full Name | Jacquelyn Lea Allen |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 17 Years |
| Location | 7450 Kessler St, Merriam, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134308745 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2010009594 (Missouri) | Secondary |
| 207Q00000X | Family Medicine | 05-38982 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Shawnee Mission | Shawnee mission, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shawnee Mission Medical Center Inc | 9537119037 | 177 |
News Archive
Allergan, Inc. today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter to its New Drug Application for LEVADEX (dihydroergotamine) inhalation aerosol for the acute treatment of migraine in adults.
A La Jolla Institute team, led by leading type 1 diabetes researcher Matthias von Herrath, M.D., has demonstrated the effectiveness of a recently developed computer model in predicting key information about nasal insulin treatment regimens in type 1 (juvenile) diabetes. Development of the software, the Type 1 Diabetes PhysioLab- Platform, was funded through the peer-reviewed grant program of the American Diabetes Association.
Ferring Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved ZOMACTON for injection in four additional pediatric indications
Just like any other virus, the coronavirus needs a host to survive. Viruses enter the cells of the human body to cause disease by attaching to a specific receptor site on the host cell membrane. To do this, they attach to proteins in the capsid through glycoproteins found in the envelope of the virus.
› Verified 9 days ago
| Entity Name | Shawnee Mission Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992735690 PECOS PAC ID: 9537119037 Enrollment ID: O20050701000310 |
News Archive
Allergan, Inc. today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter to its New Drug Application for LEVADEX (dihydroergotamine) inhalation aerosol for the acute treatment of migraine in adults.
A La Jolla Institute team, led by leading type 1 diabetes researcher Matthias von Herrath, M.D., has demonstrated the effectiveness of a recently developed computer model in predicting key information about nasal insulin treatment regimens in type 1 (juvenile) diabetes. Development of the software, the Type 1 Diabetes PhysioLab- Platform, was funded through the peer-reviewed grant program of the American Diabetes Association.
Ferring Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved ZOMACTON for injection in four additional pediatric indications
Just like any other virus, the coronavirus needs a host to survive. Viruses enter the cells of the human body to cause disease by attaching to a specific receptor site on the host cell membrane. To do this, they attach to proteins in the capsid through glycoproteins found in the envelope of the virus.
› Verified 9 days ago
| Entity Name | Shawnee Mission Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942317854 PECOS PAC ID: 1153239298 Enrollment ID: O20170209000848 |
News Archive
Allergan, Inc. today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter to its New Drug Application for LEVADEX (dihydroergotamine) inhalation aerosol for the acute treatment of migraine in adults.
A La Jolla Institute team, led by leading type 1 diabetes researcher Matthias von Herrath, M.D., has demonstrated the effectiveness of a recently developed computer model in predicting key information about nasal insulin treatment regimens in type 1 (juvenile) diabetes. Development of the software, the Type 1 Diabetes PhysioLab- Platform, was funded through the peer-reviewed grant program of the American Diabetes Association.
Ferring Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved ZOMACTON for injection in four additional pediatric indications
Just like any other virus, the coronavirus needs a host to survive. Viruses enter the cells of the human body to cause disease by attaching to a specific receptor site on the host cell membrane. To do this, they attach to proteins in the capsid through glycoproteins found in the envelope of the virus.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacquelyn Lea Allen, DO 7450 Kessler St, Ste 300, Merriam, KS 66204 Ph: (913) 632-2900 | Jacquelyn Lea Allen, DO 7450 Kessler St, Ste 300, Merriam, KS 66204 Ph: (913) 632-2900 |
News Archive
Allergan, Inc. today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter to its New Drug Application for LEVADEX (dihydroergotamine) inhalation aerosol for the acute treatment of migraine in adults.
A La Jolla Institute team, led by leading type 1 diabetes researcher Matthias von Herrath, M.D., has demonstrated the effectiveness of a recently developed computer model in predicting key information about nasal insulin treatment regimens in type 1 (juvenile) diabetes. Development of the software, the Type 1 Diabetes PhysioLab- Platform, was funded through the peer-reviewed grant program of the American Diabetes Association.
Ferring Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved ZOMACTON for injection in four additional pediatric indications
Just like any other virus, the coronavirus needs a host to survive. Viruses enter the cells of the human body to cause disease by attaching to a specific receptor site on the host cell membrane. To do this, they attach to proteins in the capsid through glycoproteins found in the envelope of the virus.
› Verified 9 days ago
Dr. Gregory T Sweat, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7301 E Frontage Rd, Merriam, KS 66204 Phone: 913-789-1940 | |
Dr. Nicholas Orion Gatz, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8800 W 75th St, Suite 300, Merriam, KS 66204 Phone: 913-722-4240 | |
Dr. Bradley D Yost, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7450 Kessler St, Ste 300, Merriam, KS 66204 Phone: 913-632-2900 Fax: 913-632-2999 | |
Dr. Suzanne Elizabeth Ozbun, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7450 Kessler St, Ste 300, Merriam, KS 66204 Phone: 913-632-2900 Fax: 913-632-2999 | |
Albert Tomasz Chmielewski, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7301 E Frontage Rd, Merriam, KS 66204 Phone: 913-789-1940 Fax: 913-384-4093 | |
Dr. Mary K Foos, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7450 Kessler St, Ste 300, Merriam, KS 66204 Phone: 913-632-2900 Fax: 913-632-2999 |